Trigenic

ADH5/ALDH/ADGRV1 variants Myelodysplastic syndrome Trigenic mutations Trio-next generation sequencing Usher syndrome

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 19 05 2021
revised: 19 07 2021
accepted: 12 08 2021
entrez: 30 8 2021
pubmed: 31 8 2021
medline: 31 8 2021
Statut: epublish

Résumé

Trio-next generation sequencing is useful to identify undiagnosed inherited diseases. We have attended a patient with trigenic

Identifiants

pubmed: 34458631
doi: 10.1016/j.heliyon.2021.e07804
pii: S2405-8440(21)01907-1
pmc: PMC8379464
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e07804

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

N Engl J Med. 2020 Oct 1;383(14):1358-1374
pubmed: 32997910
Biochem J. 2008 Aug 1;413(3):493-504
pubmed: 18412547
Lab Anim Sci. 1972 Oct;22(5):728-30
pubmed: 4343331
Am J Med Genet. 1999 Sep 24;89(3):158-66
pubmed: 10704190
Clin Genet. 1997 May;51(5):314-21
pubmed: 9212179
Clin Genet. 2021 Feb;99(2):226-235
pubmed: 33089500
J Biol Chem. 1974 Dec 10;249(23):7653-63
pubmed: 4373474
Expert Opin Drug Metab Toxicol. 2008 Jun;4(6):697-720
pubmed: 18611112
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Am J Hum Genet. 2018 Aug 2;103(2):171-187
pubmed: 30032986
Br J Ophthalmol. 1983 Jul;67(7):449-54
pubmed: 6860611
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Chem Biol Interact. 2009 Mar 16;178(1-3):29-35
pubmed: 19038239
J Speech Hear Res. 1969 Sep;12(3):541-63
pubmed: 4900022
J Chronic Dis. 1983;36(8):595-603
pubmed: 6885960
Chem Biol Interact. 2001 Jan 30;130-132(1-3):285-96
pubmed: 11306052
Bioinformatics. 2015 May 15;31(10):1599-606
pubmed: 25573915
Am J Hum Genet. 2004 Feb;74(2):357-66
pubmed: 14740321
Drug Metab Dispos. 2002 Jan;30(1):69-73
pubmed: 11744614
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4413-8
pubmed: 17360538
PLoS Genet. 2010 May 20;6(5):e1000955
pubmed: 20502675
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
PLoS Genet. 2016 Jan 07;12(1):e1005679
pubmed: 26741492
J Neurosci. 2006 Jun 14;26(24):6543-53
pubmed: 16775142
Genet Med. 2010 Aug;12(8):512-6
pubmed: 20613545
BMC Med Genet. 2018 Jun 11;19(1):99
pubmed: 29890953
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
Br J Ophthalmol. 1997 Jan;81(1):46-53
pubmed: 9135408
Biochem Soc Trans. 2002 Aug;30(4):473-9
pubmed: 12196118
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):734-43
pubmed: 15671307
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Clin Genet. 2018 Apr;93(4):812-821
pubmed: 29112224
Chem Biol Interact. 2009 Mar 16;178(1-3):36-9
pubmed: 18983993
Community Genet. 1998;1(4):223-8
pubmed: 15178965
Biochim Biophys Acta. 2015 Mar;1852(3):406-20
pubmed: 25481835
Clin Genet. 1991 Oct;40(4):304-11
pubmed: 1756603
Biochemistry. 2000 Sep 5;39(35):10720-9
pubmed: 10978156
Sci Adv. 2020 Dec 18;6(51):
pubmed: 33355142
Mol Cell. 2020 Dec 17;80(6):996-1012.e9
pubmed: 33147438
Mutat Res. 2009 Jul 31;668(1-2):4-10
pubmed: 19622403

Auteurs

Shintaro Kinoshita (S)

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.

Miki Ando (M)

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Division of Stem Cell Therapy, Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Jun Ando (J)

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University School of Medicine, Tokyo, Japan.

Midori Ishii (M)

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.

Yoshiki Furukawa (Y)

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.

Osamu Tomita (O)

Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan.

Yoko Azusawa (Y)

Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University School of Medicine, Tokyo, Japan.

Shuichi Shirane (S)

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.

Yoshihito Kishita (Y)

Diagnostic and Therapeutics of Intractable Diseases, Graduate School of Medicine and Intractable Disease Research Center, Juntendo University, Tokyo, Japan.

Yukiko Yatsuka (Y)

Diagnostic and Therapeutics of Intractable Diseases, Graduate School of Medicine and Intractable Disease Research Center, Juntendo University, Tokyo, Japan.

Hidetaka Eguchi (H)

Diagnostic and Therapeutics of Intractable Diseases, Graduate School of Medicine and Intractable Disease Research Center, Juntendo University, Tokyo, Japan.

Yasushi Okazaki (Y)

Diagnostic and Therapeutics of Intractable Diseases, Graduate School of Medicine and Intractable Disease Research Center, Juntendo University, Tokyo, Japan.

Norio Komatsu (N)

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.

Classifications MeSH